Zhongchao Inc. logo

Zhongchao Inc.

ZCMD

NASDAQHealthcareMedical - Healthcare Information Services

Previous close

$0.9285

−$0.0317 · -3.30%

Aug 21, 4:00 PM ET

ZCMD company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

47

Fair Value

Momentum

42

Neutral

Sentiment

51

Mixed

Risk resilience

37

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People's Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs. The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes on popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content. The company offers its services through its MDMOOC online platform, such as the MDMOOC mobile app, MOOC Medical WeChat subscription account, and MDMOOC website, and patient management services through an IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program. It serves pharmaceutical enterprises and non-profit organizations, including medical associations, medical institutions, medical journals, medical foundations, and hospitals, as well as healthcare professionals, nurses, and doctors. Zhongchao Inc. was founded in 2012 and is headquartered in Shanghai, China.

Industry
Medical - Healthcare Information Services
Sector
Healthcare
Headquarters
CN
CEO
Weiguang Yang
Listed since
Feb 24, 2020
Employees
33

Market position

Day range

Current $0.9285

52-week range

Current $0.9285

Open
$0.9501
Previous close
$0.9602
Volume
323.15K
0.07× average
Average volume
4.51M
Average daily volume
Market cap
32.25K USD
Beta
-0.01
Market reference 1
50-day average
$1.4854
-37.49% below average
200-day average
$198.26
-99.53% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
4.23M USD
P/E (TTM)
-0.01×
P/B (TTM)
P/S (TTM)
EV / EBITDA
-0.78×
Earnings yield
-51.28%
Free cash flow yield
5.63%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
43.84%
Operating margin
-54.43%
Net margin
-55.47%
Return on equity
-33.87%
Return on assets
-25.95%
Return on invested capital
-27.14%

Financial health

Debt / equity
Current ratio
11.11×
Altman Z-score
0.3
Piotroski F-score
4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends71%20%-30%-81%Gross margin, FY2021: 57.92%Gross margin, FY2022: 44.92%Gross margin, FY2023: 43.80%Gross margin, FY2024: 56.18%Gross margin, FY2025: 42.47%Operating margin, FY2021: -1.97%Operating margin, FY2022: -20.88%Operating margin, FY2023: -68.35%Operating margin, FY2024: -2.15%Operating margin, FY2025: -54.43%Net margin, FY2021: 1.46%Net margin, FY2022: -20.78%Net margin, FY2023: -58.33%Net margin, FY2024: -4.05%Net margin, FY2025: -55.47%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 57.92%. Gross margin FY2022 44.92%. Gross margin FY2023 43.80%. Gross margin FY2024 56.18%. Gross margin FY2025 42.47%. Operating margin FY2021 -1.97%. Operating margin FY2022 -20.88%. Operating margin FY2023 -68.35%. Operating margin FY2024 -2.15%. Operating margin FY2025 -54.43%. Net margin FY2021 1.46%. Net margin FY2022 -20.78%. Net margin FY2023 -58.33%. Net margin FY2024 -4.05%. Net margin FY2025 -55.47%.

Income trends

Revenue

11.37M USD-28.30%

Operating income

−6.19M USD-1714.19%

Net income

−6.31M USD-881.01%
Income trends across reported periods22.71M USD9.62M USD−3.47M USD−16.56M USDRevenue, FY2021: 16.3M USDRevenue, FY2022: 14.15M USDRevenue, FY2023: 19.43M USDRevenue, FY2024: 15.86M USDRevenue, FY2025: 11.37M USDOperating income, FY2021: −320.74K USDOperating income, FY2022: −2.95M USDOperating income, FY2023: −13.28M USDOperating income, FY2024: −341.27K USDOperating income, FY2025: −6.19M USDNet income, FY2021: 238.67K USDNet income, FY2022: −2.94M USDNet income, FY2023: −11.34M USDNet income, FY2024: −643.23K USDNet income, FY2025: −6.31M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 16.3M USD. Revenue FY2022 14.15M USD. Revenue FY2023 19.43M USD. Revenue FY2024 15.86M USD. Revenue FY2025 11.37M USD. Operating income FY2021 −320.74K USD. Operating income FY2022 −2.95M USD. Operating income FY2023 −13.28M USD. Operating income FY2024 −341.27K USD. Operating income FY2025 −6.19M USD. Net income FY2021 238.67K USD. Net income FY2022 −2.94M USD. Net income FY2023 −11.34M USD. Net income FY2024 −643.23K USD. Net income FY2025 −6.31M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue11.37M USD15.86M USD19.43M USD14.15M USD16.3M USD
Cost of goods sold6.54M USD6.95M USD10.92M USD7.79M USD6.86M USD
Gross profit4.83M USD8.91M USD8.51M USD6.36M USD9.44M USD
Research and development8.09K USD252.45K USD514.41K USD411.52K USD758.88K USD
Selling, general, and administrative11.01M USD9M USD13.41M USD8.9M USD9M USD
Operating expenses11.02M USD9.25M USD21.8M USD9.31M USD9.76M USD
Interest income343.13K USD243.01K USD237.05K USD142.01K USD175.99K USD
Depreciation and amortization321.67K USD428.36K USD923.61K USD730.31K USD702.98K USD
Operating income−6.19M USD−341.27K USD−13.28M USD−2.95M USD−320.74K USD
Net income−6.31M USD−643.23K USD−11.34M USD−2.94M USD238.67K USD

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
-1.43

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates31.189.9-11.39-32.68Q3 '22Q3 '22Q3 '23Q3 '24Q4 '24Q3 '25Q3 '25Q2 '26
Q3 2022, reported Aug 8, 2022: actual -2.31, estimate —, surprise —, Comparison unavailable. Q3 2022, reported Sep 30, 2022: actual 26.78, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Aug 10, 2023: actual -13.47, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Jul 30, 2024: actual -18.9, estimate —, surprise —, Comparison unavailable. Q4 2024, reported Nov 1, 2024: actual 25.37, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Jul 25, 2025: actual -1.19, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Sep 29, 2025: actual -28.27, estimate —, surprise —, Comparison unavailable. Q2 2026, reported Apr 24, 2026: actual -1.43, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates10.79M8.92M7.05M5.19MQ3 '22Q3 '22Q3 '23Q3 '24Q4 '24Q3 '25Q3 '25Q2 '26
Q3 2022, reported Aug 8, 2022: actual 7.68M USD, estimate —, surprise —, Comparison unavailable. Q3 2022, reported Sep 30, 2022: actual 7.3M USD, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Aug 10, 2023: actual 10.38M USD, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Jul 30, 2024: actual 9.06M USD, estimate —, surprise —, Comparison unavailable. Q4 2024, reported Nov 1, 2024: actual 8.35M USD, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Jul 25, 2025: actual 7.52M USD, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Sep 29, 2025: actual 5.6M USD, estimate —, surprise —, Comparison unavailable. Q2 2026, reported Apr 24, 2026: actual 5.77M USD, estimate —, surprise —, Comparison unavailable.

ZCMD news

Corporate actions

Corporate action history

Stock split

Effective Jun 29, 2026

1:3

Stock split

Effective Jun 8, 2026

1:31

Stock split

Effective Mar 2, 2026

1:8

Stock split

Effective Feb 29, 2024

1:10

ZCMD peers

Continue in GoAI

Research ZCMD

research.disclaimer